NEUROSCIENCE RESEARCH Disease Modeling Drug Discovery
Neuroscience Research

Brain Organoids

Modeling the Human Brain In Vitro

← Back to Science

BREAKTHROUGH TECHNOLOGY

Cerebral organoids are self-organizing 3D structures derived from human pluripotent stem cells that recapitulate key aspects of human brain development and architecture. First described by Lancaster et al. in Nature (2013), brain organoids have revolutionized our ability to study human neurodevelopment, neurological diseases, and drug responses in an ethically accessible human model.

RESEARCH APPLICATIONS

NEURODEGENERATION
Alzheimer's & Parkinson's Disease

Brain organoids derived from patients with familial Alzheimer's or Parkinson's disease recapitulate pathological features including amyloid plaques, tau tangles, and alpha-synuclein aggregation. These models enable drug screening in human neural tissue.

NEURODEVELOPMENT
Autism & Microcephaly

Organoids from patients with genetic neurodevelopmental disorders reveal mechanisms of disease. Studies of microcephaly using organoids led to understanding of Zika virus effects on brain development.

NEURO-ONCOLOGY
Glioblastoma Modeling

Brain tumor organoids (BTOs) and cerebral organoid-glioma co-cultures provide platforms for studying tumor invasion, drug resistance, and personalized treatment approaches.

PSYCHIATRY
Schizophrenia Research

Patient-derived organoids enable study of neurodevelopmental origins of psychiatric conditions, revealing differences in neural progenitor proliferation and synaptogenesis.

CAPABILITIES & LIMITATIONS

✓ Capabilities
  • • Human-specific neurodevelopment
  • • Patient-specific disease modeling
  • • Drug screening in human tissue
  • • Long-term culture (months-years)
  • • Regional brain specification
⚠ Limitations
  • • Lack of vascularization
  • • Absence of microglia (often)
  • • Batch-to-batch variability
  • • Size limitations (~4mm)
  • • Incomplete maturation

KEY TECHNOLOGY PROVIDERS

Platform

System1 Bio

Brain organoid platform for neurotherapeutics discovery. $25M Series A.

Nerve-on-Chip

AxoSim

Neural organoid and nerve-chip technology for CNS drug development.

Products

STEMCELL Tech

STEMdiff Cerebral Organoid Kit for research applications.

PRIMARY SOURCES

← Liver Toxicity Testing Next: Cardiac Safety →